Myriad Can't Patent Cancer Genes, ACLU Tells High Court
Patents on breast cancer genes isolated by Myriad Genetics Inc. should be invalidated because they are no different from DNA found in nature and are not based on any inventive concept,...To view the full article, register now.
Already a subscriber? Click here to view full article